Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2019

01-12-2019 | Editorial

Medicine in the era of network science

Author: Sebastiano Filetti

Published in: Endocrine | Issue 3/2019

Login to get access

Excerpt

“Organisms are information networks.”—Sir Paul Nurse, Nobel Laureate …
Literature
1.
J. Loscalzo, A.L. Barabasi, E.K. Silverman., Network medicine: complex systems in human disease and therapeutics. (Harvard University Press, Cambridge, Massachusetts, 2017)CrossRef
2.
A.L. Barabási, N. Gulbahce, J. Loscalzo, Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56–68 (2011)CrossRef
3.
J. Menche, A. Sharma, M. Kitsak, S.D. Ghiassian, M. Vidal, J. Loscalzo, A.L. Barabási, Disease networks: uncovering disease–disease relationships through the incomplete interactome. Science 347(6224), 1257601 (2015)CrossRef
4.
5.
R. Falcone, F. Conte, G. Fiscon, V. Pecce, M. Sponziello, C. Durante, L. Farina, S. Filetti, P. Paci, A. Verrienti, BRAFV600E-mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response. Endocrine 64(2), 406–413 (2019)CrossRef
6.
7.
K. Li, F. Hu, W. Xiong, Q. Wei, F.F. Liu, Network-based transcriptomic analysis reveals novel melatonin sensitive genes in cardiovascular system. Endocrine 64(2), 414–419 (2019)CrossRef
8.
S. Filetti, Quo vadis Endocrine. Endocr. Part II 63(1), 1–2 (2019)
Metadata
Title
Medicine in the era of network science
Author
Sebastiano Filetti
Publication date
01-12-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02139-w

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue

Original Article

Sleep disorders and cognitive dysfunction in acromegaly

Original Article

Effects of glucagon-like peptide-1 analog liraglutide on the systemic inflammation in high-fat-diet-induced mice

Original Article

Growth hormone therapy in children: predictive factors and short-term and long-term response criteria

Original Article

The tendency of reduced periodontal destruction in acromegalic patients showing similar inflammatory status with periodontitis patients

Original Article

Response of gut microbiota in type 2 diabetes to hypoglycemic agents

Original Article

Postprandial leptin and adiponectin in response to sugar and fat in obese and normal weight individuals
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits